Skip to content

Dr. K. Van Loon

Active
Private limited companyfounded 20233 yrs activeBrouwersdreef 23, 2820 Bonheiden, BelgiumKBO/BCE: BE 0803.970.741

Dr. K. Van Loon has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €50k and a net result of €30k. Equity is growing by ~78.5% per year across the filed fiscal years. Its solvency ranks better than 64% of 16414 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
100 / 100
Excellent▲ +7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78▲+26
Stability94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity ample (current ratio 4.14 against 2.85 in 2024), and 23.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
76.4%
Return on assets
45.9%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
64 d early
2024
3 d early
2023
21 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€50k▲ 151%
2024 · €20k
2023: €19k 2024: €20k
2023 → 2025
Total assets
€66k▲ 126%
2024 · €29k
2023: €25k 2024: €29k
2023 → 2025
Net result
€30k▲ 345%
2024 · €7k
2023: €17k 2024: €7k
2023 → 2025
Working capital
€47k▲ 178%
2024 · €17k
2023: €18k 2024: €17k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€19k-€20k▲ 6.7%€50k▲ 151%
Operating result€23k-€9k▼ 60.9%€41k▲ 361%
Net result€17k-€7k▼ 61.3%€30k▲ 345%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40kOperating result 2023: €23k€23kNet result 2023: €17k€17kOperating result 2024: €9k€9kNet result 2024: €7k€7kOperating result 2025: €41k€41kNet result 2025: €30k€30k202320242025
The operating result recovers in 2025; 2025 is 361% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €66k
Fixed assets €4k▲ 25.3%
Current assets €62k▲ 138%
Equity and liabilities €66k
Equity €50k▲ 151%
Debt €15k▲ 70.7%
The debt ratio falls from 31.2% to 23.6%: equity grows faster than debt.
Key figures and ratios
2025 value · change against 2024
EBITDA
€41k
2024 · €10k
Cash flow
€31k
2024 · €8k
Solvency
76.4%
2024 · 68.8%
Current ratio
4.14
2024 · 2.85
Quick ratio
4.14
2024 · 2.85
Debt / equity
0.31
2024 · 0.45
ROE
60.1%
2024 · 33.8%
ROA
45.9%
2024 · 23.3%
Interest coverage
20.42
2024 · 39.20
Debt
€15k
2024 · €9k
Debt ≤ 1 year
€15k
2024 · €9k
Income taxes
€9k
2024 · €2k
Staff costs
€412
2024 · €148
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€29k€66k
Formation expenses20€0-
Fixed assets21/28€3k€4k
Tangible fixed assets22/27€3k€4k
Plant, machinery and equipment23€3k€4k
Current assets29/58€26k€62k
Amounts receivable within one year40/41€11k€0
Trade receivables40€11k€0
Other amounts receivable41€2€0
Cash at bank and in hand54/58€14k€53k
Deferred charges and accrued income490/1€886€9k
Equity and liabilities
Total equity and liabilities10/49€29k€66k
Equity10/15€20k€50k
Contributions10/11€3k€3k=
Reserves13€17k€48k
Distributable reserves133€17k€48k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€9k€15k
Amounts payable within one year42/48€9k€15k
Financial debts43€14€15
Credit institutions430/8€14€15
Trade debts44€0€1k
Suppliers440/4€0€1k
Taxes, remuneration and social security45€9k€13k
Taxes450/3€9k€13k
Other amounts payable47/48€0€922
Accrued charges and deferred income492/3-€616
Income statement Code20242025
Remuneration, social security and pensions62€148€412
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€770
Other operating charges640/8€62€244
Gross operating margin9900€10k€42k
Operating profit (loss)9901€9k€41k
Financial income75/76B€616€194
Recurring financial income75€616€194
Financial charges65/66B€256€2k
Recurring financial charges65€256€2k
Profit (loss) for the period before taxes9903€9k€39k
Income taxes67/77€2k€9k
Profit (loss) for the period9904€7k€30k
Profit (loss) for the period to be appropriated9905€7k€30k
Appropriation of the result
Profit (loss) to be appropriated9906€7k€30k
Transfer to equity691/2€1k€30k
To other reserves6921€1k€30k
Profit to be distributed694/7€6k€0
Return on contributions (dividend)694€6k€0

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
28-05
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2023net €30k ▲345%
Operating result €41k, net result €30k, both a record.
28-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Weakest financial yearnet €7k ▼61.3%
Net result drops to €7k, the lowest in the series; recovery starts the following year.
10-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bonheiden · 1 establishment unit since 2025
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Brouwersdreef 232820 Bonheiden
Ground area
671 m²
Building footprint
122 m²
Volume, LiDAR
383 m³
Parcel 12005D0119/00F008, Flanders · tallest building 19.3 m. Linked by address, not a title deed.
1 establishment unit
Dr. K. Van Loon
Brouwersdreef 23, 2820 BonheidenSpecialist medical practice
since 20252.376.668.759
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12005D0119/00F008 Flanders 671 m² 1 · 122 m² 19.2 m
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

6488Z41H0G19HMQ3X329
live in the LEI register

Similar companies · same sector, comparable size

Of 16,603 companies in sector 86220 we hold annual accounts for 7,960. 5,029 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded14-07-2023
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.